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The class I  genes of the mouse are encoded in the major histocompatibility 
complex (MHC) ~ on chromosome  17. The classical transplantation antigens, K, 
D, and L, encoded by the H-2 region of the MHC, are expressed on most somatic 
cells and are used as restriction elements for the T  cell cytotoxic destruction of 
virally infected or neoplastically transformed cells. In contrast, the Qa and Tla 
regions  of the  MHC  encode  a  variety  of class  I  molecules  whose  tissues  of 
distribution are known only in a few cases and whose physiological functions are 
entirely unknown.  Fewer than  10 Qa/Tla loci have been identified by classical 
serology (4-6). Their relationship to the functionally defined products is unclear. 
Serologically defined  Qa/Tla  genes,  like  the  classical  transplantation  antigen 
genes, encode 37,000-45,000  dalton integral membrane glycoproteins that are 
associated  noncovalently with  a  12,000  dalton  polypeptide,  /32-microglobulin. 
Each  of  the  serologically  defined  Qa/Tla  polypeptides  has  a  distinct  tissue 
distribution.  For example, the TL antigens, encoded by certain Tla genes, are 
found only on thymocytes (7), some lymphoid tumors (8), and activated T  cells 
(9).  The  Qa-2  antigen  appears  to  be  confined  to  hematopoietic  tissues,  T 
lymphocytes, and B lymphoblasts (4). The Qa-1  antigen has been reported to be 
expressed on all lymphoid cells in the spleen and preferentially expressed on a 
T  lymphocyte subpopulation (5,  6). Some of the Qa/Tla proteins expressed on 
mature lymphocytes have been  reported to give rise to H-2-unrestricted  weak 
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graft rejection responses and secondary T  cell cytotoxicity reactions (1-3). The 
mechanism by which specific cytotoxic T  cells recognize and kill Qa-bearing cells 
is unknown. 
Recently,  DNA  clones cross-hybridizing  to  those  of the  K,  D,  and  L  genes 
were isolated, mapped to the MHC, and characterized (10-15).  10 class I genes 
were mapped to the Qa-2 region (Ql-lO) of the inbred BALB/c mouse, and  18 
others were assigned to the Tla region  (14;  D.  Fisher,  S.  Hunt,  and  L. Hood, 
manuscript  in preparation).  To study protein  products of these sequences,  the 
genes were introduced  into  L  cells by DNA-mediated gene transfer,  and their 
cell  surface expression  was monitored  with  monocional  antibodies specific for 
class I molecules (13,  16).  Only a few gene products were detected by this assay 
and  the serologically defined Qa-2  molecules were not conclusively identified. 
The remainder  of the genes may encode the following classes of molecules: (a) 
proteins that do not react with the monoclonal antibodies used, (b) tissue-specific 
molecules that  are not expressed on transfected fibroblasts or are expressed at 
very low levels, (c) secreted proteins, or (d) proteins confined to the cytoplasm. 
Alternatively, some of the unexpressed class I genes could be pseudogenes. 
We were interested in studying the structure, expression, and T  cell recogni- 
tion properties of these molecules. For the initial analysis we chose the Q6 gene 
from  the  BALB/c  Crgl  (Qa-2 a)  mouse  (previously  designated  as  gene  27.1), 
because  its  complete  nucleotide  sequence  is  known  (10)  and  because  it  was 
negative  in  the  transfection  assay  described  above.  This  gene  was  proposed 
recently to be an allelic equivalent of the H-2  b Q7 gene from C57BL/10 mouse 
(17). The  BALB/c Q6 gene has an exon structure similar to that  of the K,  D, 
and L genes. Exon  1 encodes the leader peptide; exons 2-4 the three external 
domains  al,  a2,  and  a3;  exon  5  the  transmembrane  and  a  portion  of the 
cytoplasmic domain;  and  exons  6-8  the  remainder  of the  cytoplasmic region. 
The  Q6 gene has a  stop codon located at the  3'  end of exon 5, resulting in a 
cytoplasmic  region  of only  three  positively  charged  residues.  Thus  the  Q6 
potypeptide, if expressed,  would be some 25 amino acid residues shorter  than 
the typical transplantation  antigen (see below). 
To characterize  the coding properties of the Q6 gene,  we have constructed 
hybrid class I genes by splicing 5' and 3' portions of Q6 gene to the complemen- 
tary ends of the  K d,  D a,  and  L d genes.  In  some cases the hybrid class I  genes 
were expressed on the cell surface after transfection into mouse fibroblasts. We 
report  here  serological,  biochemical,  and  functional  characterization  of the 
hybrid  gene  products  and  define  regions  on  the  Q6  molecule  that  contain 
polymorphic determinants recognized by anti-class I monoclonal antibodies and 
anti-Qa-2 region-specific alloreactive cytotoxic T  cells. 
Materials and Methods 
Materials.  The Q6, L  d, D  d, and K  d genes were derived from clones X27.1 (10), ~,27.5 
(18), c 18.1 (11), and ~ 1-3 (13), respectively.  Restriction  enzymes were purchased from 
New England  Biolabs; Bethesda Research Laboratories, Gaithersburg, MD; and Boehrin- 
ger Mannheim  Biochemicals, Indianapolis,  IN. T4 DNA ligase was obtained from Boeh- 
ringer Mannheim  Biochemicals. DNA were propagated in Escherichia coli strain MC 1061. 
Monoclonal antibodies have been previously described (19-21). D3.262 is a monoclonal 
antibody described elsewhere (22). The 66-4-8 antibody has been recently isolated  (S. STROYNOWSKI  ET  AL.  937 
Chatterjee-Das, D. Hernandez, and D. H. Sachs, manuscript in preparation). The B6.K1 
anti-B6  and  B6.K1  anti-B6.K2  antisera  were  kindly  provided  by  Lorraine  Flaherty, 
Department  of Health,  Albany,  NY.  Anti-H-2  k serum  was  produced  by  immunizing 
B10.D2  mice with BI0.BR cells.  Animals were bred in the University of Texas Health 
Science Center at Dallas colony or purchased from The Jackson Laboratory, Bar Harbor, 
ME. 
Construction of Recombinant Class I Genes.  Recombinant genes were constructed using 
standard molecular biology techniques (see Fig.  1). A 3 kb BglII-BamHI fragment of the 
Q6 gene derived from ~27.1  (10) and containing exons 1-3 and 926 basepairs (bp) of 5' 
flanking  region  was  cloned  into  the  BamHI site  of pBR322.  The  resulting  plasmid, 
p1104.4,  was linearized with BamHI enzyme, and 2.4 kb BamHI fragments from X27.5 
(17) or cl 8.1  (11), containing exons 4-8, were inserted, making Q6/L"and Q6/D  a genes, 
respectively. To construct the hybrid Q6/K  a gene, we cleaved pl 104.4 with BamHI and 
EcoRI and inserted a 3.7 kb BamHI-EcoRI K  d fragment containing exons 4-8 and derived 
from X  1-3 (13). The hybrid Ld/Q6 gene was constructed by insertion of a 2.6 kb BamHI 
fragment (exons 4-8) from ~27.1  into a  unique  BamHI site of plasmid 2001  described 
previously (23).  The Ld/Q6 construct has -6 kb of 5' flanking region and ~3 kb of 3' 
flanking region.  The identity of all the constructs was verified by extensive restriction 
enzyme analyses. 
Transfection  of Mouse Fibroblasts and  Maintenance  of Cell  Lines.  Mouse  thymidine 
kinase-negative cells (Ltk-) derived from C3H  mice (H-2  k) were used as recipients  in 
transfection experiments. They were maintained in alpha minimal essential medium (cr- 
MEM) (Irvine Scientific, Santa Ana, CA) containing 10% fetal calf serum (FCS), glutamine, 
streptomycin, penicillin, and bromodeoxyuridine. Transfection was performed as previ- 
ously described  (24)  using ~1  ~g of plasmid or ~ phage  DNA,  20  ng of ptk5  (herpes 
simplex thymidine kinase gene cloned in pBR322), and 20 #g of Ltk- carrier DNA per 5 
×  106-107  Ltk- cells.  The Ltk  + transfectants were selected in medium containing hypo- 
xanthine, aminopterine, and thymidine (HAT). 
Radioimmunoassay and Immunoprecipitations.  Radioimmunoassays were performed as 
previously  described  (24).  Briefly,  an  appropriate  dilution  of monoclonal  hybridoma 
antibody was mixed with 5 ×  105 trypsin-dispersed Ltk  + cell transfectants, and incubated 
4 h at 4°C in microtiter plates.The cells were washed twice and suspended in a medium 
containing  tzSI-protein A  (Amersham Corp.,  Arlington  Heights,  IL). The plates were 
incubated overnight at 4°C and the cells were washed twice and counted in Gamma 5500 
counter (Beckman Instruments,  Inc., Fulterton,  CA).  The experimental errors did not 
exceed  5%.  For  immunoprecipitations,  the  transfected  cells  were  labeled  with  [3H]- 
phenylalanine  (New  England  Nuclear,  Boston,  MA;  Amersham  Corp.)  as  previously 
described  (24,  25).  Immunoprecipitated class  I-like molecules were  analyzed by two- 
dimensional gel electrophoresis (25). 
lmmunofluorescence  Staining  and  Flow  Microfluorometry  (FMF)  Analysis.  Immuno- 
fluorescence staining was performed as previously described (26). For indirect staining, 6 
×  105 cells, harvested by trypsinization, were incubated for 45 rain at 4°C with monoclonal 
antibodies, washed twice, and incubated for 45 min with fluorescein (FITC)-goat isothio- 
cyanate F(ab')~ anti-mouse IgG (60429; Boehringer Mannheim Biochemicals). After this 
incubation,  cells were washed twice and  resuspended  for FMF analysis.  For inhibition 
experiments, cells were incubated at 4°C for 60 min with the antibody being tested for 
blocking activity. After 60  min,  fluorescein-conjugated antibody was added  in  limiting 
amounts and the incubation was continued for 20 rain. After this incubation, cells were 
washed twice, resuspended, and analyzed for fluorescence. 
FMF  analysis  was  performed  as  previously  described  (26)  using  a  FACS  II  (B-D 
Automated Immunochemistry, Becton, Dickinson & Co., Salt Lake City, UT).  Fluores- 
cence  data  were  collected  using  logarithmic  amplification  on  50,000  viable  cells  as 
determined by forward light scattered intensity. Logarithmic amplification was provided 
by a  3-decade  logarithmic amplifier constructed  from an  NIH  modified design  of R. 
Hiebert,  Los  Alamos Scientific  Laboratory (Los Alamos,  NM).  Data are displayed as 
immunofluorescence profiles in which logarithmically increasing fluorescence intensity is 938  CODING  PROPERTIES  OF  Qa  HYBRID  GENES 
plotted on the x axis and cell number is shown on the y axis. Logarithmic values of median 
fluorescence intensity were converted to linear units of V (volts ×  10  4) using a calibration 
curve  generated  on  the  amplifier  used.  Data  from  the  inhibition  experiments  were 
calculated using the formula: percent inhibition ---  100 -  [(Vexp -  Vbkg)/(Vco, -- Vbkg)], 
where V  is  linear units of mean fluorescence intensity; exp,  cells  stained with  FITC- 
antibody in the presence of a potential inhibitor; con, cells stained with FITC-antibody in 
the presence of media; and bkg, unstained cells. 
Generation and Assay of Cytotoxic T  Cells.  Anti-H-2  and  anti-Qa-2  region-specific 
cytotoxic T  cells were  generated as  described previously (11,  22).  Briefly, anti-Qa-2 
cytotoxic T  cells were generated by priming B6.K1 (Qa-2  b) mice in vivo with A.BY (Qa- 
2  a) spleen cells,  followed by in vitro challenge with (Qa-2")  B6.K2 congenic cells.  The 
mice were challenged in vitro no sooner than 4 wk after priming. The 51Cr assay against 
L cells, including inhibition with antibody, has been described (27). Data are presented as 
net release of isotope from target cells. Net release equals percent release of isotope from 
target cells  in  the  presence of effector cells  minus  spontaneous  release.  Spontaneous 
release from L cells was between 10 and 20%, and from B6.K2 target cells, between 25 
and 35%. The standard error of the mean of triplicate samples did not exceed 2%. 
A number of controls for the experiments described in Fig.  4 were carried out. First, 
to eliminate the possibility that, in the B6.K1 anti-B6.K2 sensitization, anti-H-2  k cytotoxic 
T  cells are generated that preferentially lyse Q6/Ld-expressing cells,  we crossed B6.K1 
animals to C3H (H-2  k) animals and tested the (B6.K1 x  C3H)F~ offspring for their ability 
to generate cytotoxic T  ceils that would lyse Q6/L  a cells. This experiment is important 
because the mouse L cells are of the H-2  k haplotype. The lytic activity of cytotoxic T cells 
generated in  this  experiment was  comparable to that  observed using parental  B6.K1 
cytotoxic T cells. Second, to confirm that the determinant recognized by cytotoxic T cells 
is  localized  on  the  al-a2  domain  contributed  by  the  Q6  gene,  and  not  on  a3-/32- 
microglobulin domain contributed by the L  d gene, we tested cells transfected with the 
hybrid Q6/D  d gene. As predicted, these cells were lysed by both types of anti-Qa-2 region 
cytotoxic  T  cells described above. Finally, to independently test the activity of anti-Qa-2 
region cytotoxic T  cells,  we sensitized BALB/cBy (Qa-2  b) with BALB/cJ (Qa-2  a) spleen 
cells. The lytic activity of these cytotoxic T  cells was less than that of the B6.K1 killer T 
cells described above. However, they did specifically lyse the Q6/L  n target cells (data not 
shown).  These results  taken together indicate that  anti-Qa-2  region cytotoxic T  cells 
recognize antigenic determinant(s) on the a l-a2 domain of Q6 hybrid gene products. 
Results 
Strategy  for Testing Coding Properties of Q6 Gene.  The Q6 gene appears to be 
functional by sequence criteria (see Discussion), yet its product is not detectable 
by  cell  binding  radioimmunoassay  after  transfer  into  mouse  fibroblasts.  This 
could result from the use of the reagents not specific for Q6 product, from the 
lack of Q6 expression on the cell surface of transfectants, or both.  In any case, 
the Q6 gene is, in this system, operationally nonfunctional. Our approach to the 
study of the Q6 protein is to construct recombinant Q6/L  d genes, transfer them 
into fibroblasts, and characterize the properties of Q6-encoded domains in the 
context of hybrid molecules. The rationale for constructing these hybrids is as 
follows.  (a)  The exon-intron structure of all class  I  genes is virtually identical. 
Thus,  homologous  sequences  encoding  different  domains  can  be  exchanged 
between  the  L d  and  Q6  genes  without  introducing  reading  frameshifts  or 
deletions.  The  same  is  also  true  for  the  K d and  D d  genes.  (b)  The  external 
portions of class I  molecules, o~1  and 0~2, appear to fold together to generate a 
single a 1-or2 domain, and the o~3 region and ~32-microglobulin fold together to 
generate a second external domain (23, 28-30). This conformation is analogous Polypeplide  region 
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FIGURE  1.  Exon-intron structure of (a)  class  I  genes and  (b) the recombinants.  Exons are 
presented  as  filled boxes;  5',3'  flanking  regions  and  introns  as  open  boxes.  Waved  lines 
correspond to pBR322 plasmid DNA into which the genes were cloned. Restriction sites:  B, 
BamHl; Bg, BglII; RI, EcoRI; HIII, Hind]II; B/Bg, hybrid site created by ligation of BamHI 
and BgllI sticky ends and no longer recognized by either enzyme; B*, modified BamHI site 
no longer recognized by BamHI. 
to  the  folding  of the  light  and  heavy  chain  variable  (VL and  Vn)  regions  of 
immunoglobulins to form the V domain, and the folding of the L chain constant 
(CL) and  H  chain  constant  (C,)I  regions  to  form  C.I  domain  (31).  Thus, 
polymorphic determinants recognized by antibodies will generally be on the al- 
oe2 domain  or c~3-~2-microglobulin  domain,  but  not on  both.  Hence,  the  two 
distinct domains can be shuffled between different class I molecules (23, 28-30). 
The hybrid class I genes should join exons  1-3 (leader,  otl, a2) from one gene 
with exons 4-8  from the second gene (a3,  carboxyl terminus).  Fig.  1 presents 
the  structure  of the  recombinant  class  I  genes constructed according  to these 
assumptions.  Two  BamHI  sites are  conserved between Q6 and  L d sequences. 
One of them is located in the third intron, and the second is located downstream 
from the polyadenylation site. Hence, these sites can be used to construct hybrid 
Q6/L  d genes in  which  the  leader,  al,  and  or2 regions are encoded by the  Q6 
gene,  the remainder  of the molecule by the  L d, and  vice versa.  The details of 
the  hybrid  gene  constructions  are  presented  in  Materials  and  Methods.  (c) 
Monociona] antibodies  have  been  identified,  for the  L d gene products,  which 
recognize the 0ll-t~2 (30-5-7) or the ot3-13~-microglobulin  (28-14-8) domains (23, 
28). These two monoclonal reagents can be used to detect hybrid Q6/L  a (exons 
1-3 from Q6 and exons 4-8 from L d) gene product (reagent 28-14-8) or hybrid 
Ld/Q6 gene product (reagent 30-5-7). The properties of the Q6 portion of the 940 
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FIGURE 2.  Results  of cell binding radioimmunoassay on cloned L cells transfected with class 
I genes. The tests were carried  out with 10  -2 dilutions of ascites fluids or concentrated 
supernatants of hybridomas containing 30-5-7, 28-14-8, 20-8-4, 34-5-8, and 34-2-12 mono- 
clonal antibodies. The numbers shown are the average of four experiments. The experimental 
errors are <10% of the values shown. K  a transfectant used in these experiments as control is 
an unstable line and expressed K  a molecules at low levels. All other transfectants were stable 
for one year when grown in a-MEM medium with HAT, glutamine, FCS, and antibiotics. 
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hybrid can be analyzed using different serological reagents and T  cell cytotoxicity 
assays. 
Hybrid  Q6/L d  Gene  Is  Expressed  on  Mouse  L  Cells.  The  Q6/L  d  gene  was 
introduced into Ltk- fibroblast cells derived from C3H mice (H-2  k) by cotrans- 
fection with herpes virus thymidine kinase gene as previously described (12,  13). 
The Ltk  + transfectants were tested by radioimmunoassay for the expression of 
hybrid Q6/L  a antigens using the 24-14-8 and 30-5-7 monoclonal antibodies that 
recognized the a3-/32-microgiobulin and ~ 1-o~2 domains of the L a gene product, 
respectively (Fig. 2). The 28-14-8 reagent reacted with the Q6/L  d transfectants, 
but the 30-5-7 reagent did not. Neither antibody reacted with the untransformed 
mouse L cells. These observations suggested that a hybrid Q6/L  d class I molecule 
was expressed on the surface of the transfected mouse fibroblasts. 
To determine whether  the  a l-~2  domain  contributed  by the  Q6  gene  had 
antigenic determinants crossreacting with monoclonal reagents to various trans- 
plantation  antigens,  we  tested  the  Q6/L  s  transfectants  by  radioimmunoassay 
using a  variety of additional monoclonal reagents: 34-1-2 (anti-K  s, -D  s, -K  b, -L  d, 
-r,-s, -p, -q), 20-8-4 (anti-K  d, -K b, -r,-s),  34-5-8 (anti-DS), and  34-2-12 (anti-Dd). 
The 34-1-2 and 20-8-4 antibodies reacted with Q6/Ld-transfected cells but not 
with the recipient Ltk  + cells (Fig.  2). The observed crossreactivities suggest that 
the Q6 o~l-a2 domain contains antigenic determinants similar to those found on 
the classical transplantation antigens. 
We also demonstrated that an alloantiserum specific for molecules encoded by 
the Qa-2  region (B6.K1  anti-B6.K2) reacted with  Q6/L  s hybrid molecules (see 
below).  This  antiserum  does  not  crossreact  with  any  known  determinants  on 
transplantation  antigens  and,  accordingly,  this observation  suggests  that  there 
are antigenic determinants on the a 1-~2 domains of the hybrid Q6/L  s molecule 
that are not found on the classical transplantation antigens. 
We have extended our serological analyses using FMF analysis. In direct typing 
experiments, mouse L  cells transfected with Q6/L  s gene were positive with the 
28-14-8,  20-8-4,  and  34-1-2 antibodies, and  negative with  30-5-7 (anti-L  s, -D q, 
-Lq), 31-3-4 (anti-KS), 34-5-8 (anti-Dd), 23B10.1  (anti-L  d, -O  q, -Lq), 28-13-3 (anti- STROYNOWSKI ET AL.  941 
K b, -f), 66-4-8 (anti-Dq, -D  d, -L  d, -D b, -D  s, -f, -p, -r), D3.262 (anti-Qa-2a), 28-8-6 
(anti-K  b, -Db), and 34-7-23 (anti-K  d, -D  d, -K  b, -q) reagents (data not shown). 
To determine the molecular weight of the hybrid Q6/L  d gene product and to 
verify that the determinants recognized by the antibodies on Q6/L  d transfectants 
are expressed on  the same polypeptide,  monoclonal antibodies  20-8-4  (a l-a2 
domain  of Q6)  and  28-14-8  (ot3-/32-microglobulin  domain  of L d)  were  used 
independently  to  immunoprecipitate  the  Q6/L  d  gene  products  (Fig.  3).  In 
addition,  we tested the transfected products by precipitation  with an alloanti- 
serum specific for molecules encoded in  Qa-2 region (B6.K1  anti-B6.K2,  data 
not  shown).  The  immunoprecipitates  were  analyzed  by  two-dimensional  gel 
electrophoresis and compared with class  I molecules of the d haplotype precipi- 
tated from L cell transfectants. In each case, the Q6/L  d products precipitated in 
association with the ~12,000 mol wt polypeptide, ~2-microgiobulin. The larger, 
45,000  mol wt molecules display isoelectric heterogeneity characteristic of gly- 
cosylated class I products (13). The Q6/L  d polypeptides immunoprecipitated by 
each of these antisera are identical to each other and clearly different from L  d, 
K  ~, or D  d polypeptides precipitated from L cell transfectants or BALB/c spleen 
(12,  13,  23). The control experiments showed that 28-14-8 and 20-8-4  mono- 
clonal antibodies and B6.K1  anti-B6.K2 serum do not precipitate any molecules 
from the untransfected L cells. These experiments establish that Q6/L  d polypep- 
tide is an ~45,000 tool wt protein which carries antigenic determinants charac- 
teristic of the transplantation antigens as well as Qa-2 molecules. It is expressed 
on the cell surface of the transfectants in association with/32-microglobulin. 
Antibodies  Against  K a Molecules  and  Antigens  Encoded  by  Qa-2  Region  Detect 
Distinct  but  Spatially  Related  Determinants  on  the  Q6/L d Molecules.  To  locate 
relative positions of determinants recognized by 20-8-4, 34-1-2, and B6.K1 anti- 
B6  serum on  the Q6/L  d molecules, we performed inhibition  studies (Fig.  4). 
Binding of both  20-8-4  and  34-1-2  monoclonai antibodies to  Q6/L  d products 
could be blocked by each other or by B6.K1  anti-B6.K2  serum. No inhibition 
was  seen  with  L d  a3-fl2-microglobulin  domain-specific antibodies  positive  in 
direct typing experiments (28-14-8), or with monoclonal antibodies negative in 
the direct typing experiments (34-5-8, D3.262).  In contrast, the reactivity of K d 
gene transfectants with  20-8-4  or  34-1-2  monoclonal antibodies could not be 
inhibited by B6.K 1 anti-B6 serum. Clearly, the determinants detected by B6.K1 
anti-B6 serum are absent from K  d transplantation antigens but present on the 
Q6/L  d epitope spatially related to 20-8-4- and 34-1-2 Kd-like determinants. This 
inhibition  analysis  has  led  us  to  propose  that  the  Q6  gene  may encode the 
serologically defined, Qa-2 region-specific antigen described previously on sub- 
populations of lymphocytes (see Discussion). 
Q6/K a and  Q6/D d Hybrid  Genes  Are Also Expressed  on the Surface of Mouse L 
Cells.  We have considered the possibility that the polymorphic determinants 
detected by 20-8-4 and 34-1-2 on the al-0t2 domain of Q6/L  d are created by the 
interaction of the al-a2 domain of Q6 with the a3-/32-microglobulin domain of 
L d. To exclude this possibility, hybrid Q6/K  d and Q6/D  ~ genes were constructed 
(see Materials and  Methods and  Fig.  1) and transfected into mouse L  cells as 
described above. Both hybrid genes express class I gene products detectable with 
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FIGURE 4.  Analysis of serological determinants on Q6/L  d and K  d antigens by blocking with 
specific antibodies. Inhibition of binding of specific antibodies: 20-8-4 (a, c) and 34-1-2 (b) to 
L cells transfected with Q6/L  d (a, b) and K d (c) genes.  L cell transfectants were reacted with 
media or the following blocking reagent: 28-14-8 (anti-La), D3.262 (anti-Qa-2), or B6.K1 anti- 
B6 sera (anti-TLa complex). 
cells react with 34-2-12, a monoclonal antibody specific for the o~3-#2-microglob- 
ulin domain of the  D ~ molecule (23, 28). These results confirm that serological 
determinants detected on the c~ l-~z2 domain are not dependent on the presence 
of a particular c~3-#2-microglobulin domain in the Q6 hybrids. These observations 
further support the hypothesis that  these regions fold to constitute two distinct 
external domains. 
Hybrid Ld/Q6 Polypeptides Are Not Expressed on Mouse L  Cells.  The  Qa and 
Tla  genes  are  expressed  only  in  certain  subpopulations  of  lymphocytes,  in 
contrast to the transplantation  antigens,  which appear to be expressed on most 
somatic tissues. Accordingly, the L d, K d, and D d genes are readily expressed in 
mouse L cells, whereas many Tla complex genes, including the Q6 gene, are not 
(13).  One explanation  for  this  behavior  is  that  the  Q6  gene encodes features 
which control tissue expression. Certainly the observation that the 5' portion of 
the  Q6  can  be expressed at  high  levels as a  Q6/K  d,  Q6/D  d, or Q6/L  d hybrid 
gene  is  consistent  with  the  notion  that  this  feature  is  not contained  in  the  5' 
portion  of the  Q6  sequence.  Clonal  analysis  showed  that  >90%  of the  cells 
derived  from  the  pool  of Q6/Ld-transfected  fibroblasts  were  positive  for  the 944  CODING PROPERTIES OF  Qa  HYBRID GENES 
expression of Q6 determinants (data not shown). Thus, transcription from the 
chromosomal promoters located upstream  of Q6/L  d integration  sites appears 
unlikely, as such events would be expected to occur with low frequency. The 
possibility that the recombinant genes are transcribed from sequences within the 
bacterial plasmid was excluded by the analysis of deletion mutants lacking 5' 
flanking regions (data not shown). We propose that the 5' flanking region (926 
nucleotides) upstream from the Q6 gene encodes a promoter that functions as a 
transcription initiation site in fibroblasts and that the 3'  portion of the gene is 
responsible  for  the  lack  of Q6  cell  surface expression.  Accordingly, we con- 
structed an La/Q6  hybrid gene (5'  flanking sequence and exons  1-3  from L d 
and exons 4-8, and 3'  flanking sequence including polyadenylation site, from 
Q6)  (Fig.  1).  This  gene  was  introduced  into  L  cells,  and  its  expression  was 
monitored by cell binding radioimmunoassay using monocional antibody 30-5-7 
(specific for al-a2 domain of L a) (Fig. 2). In addition, intact Q6 gene transfectants 
were tested by immunoprecipitation of whole cell lysates and culture supernatants 
using monoclonal antibody 20-8-4  (specific for al-o~2  domain of Q6) (data not 
shown).  No  crossreacting class  I  gene products were detected in  either case. 
Thus,  the  2.6  kb  BamHI  fragment encoding the  3'  portion  of the Q6  gene 
appears  to  contain a  sequence that  suppresses the expression of the 5'-coded 
determinants on the L  d and Q6 molecules. Different types of phenomena could 
be involved (see below). We are currently testing whether the 3' end-encoded 
feature exerts its eft~ect at the RNA or the protein level. 
Cytotoxic T Cells Reactive With Qa-2 Region Antigens Recognize the al-a2 Domain 
of Q6/L ~ Molecule.  The specific alloreactive cytotoxic T  cells also can be used 
to characterize antigenic determinants on the hybrid Q6/L  d molecules. Forman 
et al. (22) have previously generated cytotoxic T  lymphocytes by immunization 
of B6.K1  (Qa-2 b) mice with  B6.K2  (Qa-2  a) spleen cells. The chromosomes of 
these two recombinant strains,  B6.K1  and B6.K2,  are identical except for the 
area defining the Qa-2 region (6).  Therefore, the alloreactive cytotoxic T  cells 
produced by this immunization would be expected to react against haplotype- 
specific  determinants of class  I  molecules encoded by  the  Qa-2  a region  and 
expressed on the spleen cells of B6.K2  mice. One serologically defined class  I 
molecule, Qa-2, is known to be encoded by this region. It has been shown that 
monoclonal antibodies directed against the Qa-2  molecule block only partially 
the activity of the Qa-2 region-specific cytotoxic T  cells (22). Therefore, these 
cytotoxic T  cells may detect Qa-2  region-encoded specificities other than  the 
Qa-2"  molecule.  To  test  whether the  Q6  molecules could  serve as  potential 
targets for alloreactive cytotoxic T ceils, we tested T cells generated in the B6.K1 
anti-B6.K2  combination on  mouse L  cells transfected with  the hybrid Q6/L d 
gene.  Fig.  5  demonstrates that  cytotoxic T  cells specific for the Qa-2  region 
recognize and kill  L cell transfectants expressing Q6/L  d molecules, but not the 
control Ltk  + recipients or L cells transfected with the L d gene. Thus the Q6/L  a 
gene product clearly expressed Qa-2 region-coded determinants that can readily 
be detected with Qa-2-specific alloreactive T  cells.  A  number of controls were 
carried out to establish that the Qa-2-specific killer T  cells were directed against 
determinants on  the al-c~2  domain of the Q6/L  d gene product (see Materials 
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from Ltk (a) and L d (b) and Q6/L d (c) cloned transfected lines. The following primary cytotoxic 
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C57BL/6  anti-BALB/c  (anti-H-2 d) (O);  C57BL/6  anti-CBA  (anti-H-2 k) (V);  and  din2  anti- 
BALB/c (anti-H-2L  e) (*).  Cytotoxic T  cells generated against H-2 b and H-2fantigens  lyse L d- 
transfected  cells,  indicating that there  is some crossreactivity  between  L d antigen and deter- 
minants expressed by H-2 b and H-2 r splenocytes at the cytotoxic T  cell level 
nowski et al.  (23),  Allen et al.  (29), and Arnold et al.  (30),  which indicate  that 
the  ~l-a2  but not the a3-/32-microglobulin  domain of transplantation  antigens 
carry polymorphic determinants recognized by T  cell receptors of cytotoxic T 
cells. 
To determine  whether  the  Q6/L d molecules carry  determinants  recognized 
by other alloreactive cytotoxic T cells and to exclude the possibility of nonspecific 
crossreactions,  we generated  killer  T  cells against splenocytes from mice of H- 
2 k,  H-2 d,  H-2 f,  and  H-2 b haplotypes  and  tested  them  on  Ltk  +  cells  and  on 
fibroblasts  transfected  with the  L d and Q6/L d genes  (Fig.  6).  All  three  target 
cells were sensitive to the lytic effects of anti-H-2 k killer T  cells (B6 anti-CBA), 
as expected, since L cells express H-2 k antigens. Cytotoxic T  cells directed against 
H-2 d antigens (B10.BR  anti-BALB/c  and B6  anti-BALB/c)  lysed  Ld-expressing 
mouse L cells, while Ltk cells and fibroblasts transfected with Q6/L d genes were 
not killed.  Cytotoxic  T  cells  generated  against  H-2 b (B10.BR  anti-B6)  did  not 946  CODING  PROPERTIES  OF  Qa  HYBRID  GENES 
100 
a)  b) 
80 




_Z  , 
ZO 
,  ~  4-  ±  BLOCKING 
~ ~  ~ ,~  ~  b  ANTIBODY 
FIGURE 7.  Ability of antibodies directed against the  Qa-2  subregion-coded  molecules to 
block activity of cytotoxic T  cells. Blocking of cytotoxic T  cell-mediated lysis with antibodies 
51  d  is shown as percent inhibition of net release of  Cr from Ca) B6.K2- or (b) Q6/L -transfected 
cloned target cells in the presence of B6.K1  anti-B6.K2 effector cells. Antibodies used for 
inhibition of lysis included: D3.262 (anti-Qa-2") {F1); B6.K 1 anti-B6.K2 (alloantiserum-specific 
for Qa-2 region (IN); 28-14-8 (anti-L") (IN); and alloanti-H-2  k serum (H-2  a anti-H-2  k) CO). Percent 
inhibition =  [ 1 -  (net release in the presence of antibody/net release in the presence of control 
sera)] x  100. Net release from B6.K2 and Q6/L  a target cells in the absence of sera was 36% 
in both cases. 
lyse Ltk cells or cells expressing Q6/L  ~ molecules. These results show that Q6/ 
L  d molecules are not recognized by cytotoxic T  ceils with specificities directed 
against transplantation antigens. Thus, the structural determinants on Q6 hybrid 
molecules that define T  cell receptor specificity are distinct from those found on 
class I molecules. 
Cytotoxic T  cells can be used to determine whether the serologically defined 
Qa-2  molecule and hybrid Q6  molecule share polymorphic determinants. We 
used an anti-Qa-2 monoclonal antibody and an anti-Qa-2 region alloantiserum 
to block the Qa-2-specific T  cell killing of the various L cell transfectants and 
spleen cells. The assumption is that antibodies recognizing the same structural 
regions as the cytotoxic T cells will block killing. The B6.K1 anti-B6.K2 cytotoxic 
T  cells were tested for their lytic effect against B6.K2  (Qa-2  a) target cells (Fig. 
7). In the presence of an anti-Qa-2 alloantiserum, the lytic effect was blocked, as 
previously demonstrated (22). Further, using the anti-Qa-2 monoclonal antibody 
D3.262,  we were able to block a portion but not all of the T  cell lytic activity 
against normal spleen cells (Fig. 7 and reference 22). As a control, we show that 
this cytotoxic effect was not inhibited by anti-H-2 k sera. When the cytotoxic T 
ceils  were  tested  against  the  Q6/L  d  target  cells,  we  were able  to  block  the 
cytotoxic effect with the anti-Qa-2 region alloantiserum, B6.K 1 anti-B6.K2. The 
monoclonal antibody D3.262  had no blocking effect. Thus, Q6-encoded deter- 
minant(s) recognized by cytotoxic T cells can be blocked by an antiserum directed 
against the multiple antigenic specificities of the Qa-2 region, but not by a single 
monoclonal antibody directed against a specific Qa-2 molecule. Clearly, the Qa- 
2 region encodes a multiplicity of different antigenic determinants that may be STROYNOWSKI  ET  AL.  947 
found on distinct class I  molecules. Alternatively,  D3.262 antibody reacts with 
the a3 domain of the Q6 molecule not present in the Q6/L  d hybrid. 
Discussion 
o~1-o~2 Domain  of the  Q6  Polypeptide  Is  Approximately  as  Closely  Related  to 
Homologous  Domains  in  Transplantation  Antigens  as  to  Those  of Other Qa  Anti- 
gen.  Amino  acid  comparisons  of the  al-a2  domain  of six  different  class  I 
polypeptides (10,  18, 33-40) reveal that  33 differences separate the K d and  L d 
al-a2  domains,  whereas 32 differences distinguish  the homologous K b and  D b 
regions. The Q6 al-a2 domain differs from those of the K d and L d polypeptides 
by 37 and 39 residues, respectively. The differences are scattered in a  182 amino 
acid sequence of the al-ot2 domains.  Thus,  the Q6 antigen  is no more Kd-like 
than Ld-like in its N terminus, and the presence of Q6 polymorphic determinants 
recognized by 20-8-4 and  34-1-2 antibodies and  similar  to those found on K d 
antigen cannot merely be attributed to a translocation or recombination of a K d- 
like gene to Qa-2 region. The Q6 a l-a2 external domain differs from the H-2  b 
Q10-secreted class I product (39) by 37 residues.  No unique amino acid substi- 
tutions  common  to  Q6 and  H-2  b QI0  and  absent from  other  transplantation 
antigens could be identified with the exception of a change of aspargine to lysine 
at position  176 in the a2 region. This change,  leading to a  loss of glycosylation 
site, is also present in the HLA B7 allele (41). Its functional significance, if any, 
is not known. Thus, the coding sequences of the Q6 and H-2  b Q10 genes differ 
as extensively from one another as either does from those of the transplantation 
antigens.  Perhaps gene conversion events are frequent among the class I genes 
of the  H-2 and  Qa/Tla  regions and  this  correction process leads to the  rapid 
divergence and shuffling of the coding sequences (42, 43). One wonders if the 
structural  similarities of the classical transplantation  antigens and  the Qa poly- 
peptides reflect similar functions of these antigens. 
Q6 Gene May Encode CR (Crossreactive)  Antigen.  The serological and killer T 
cell analyses described in this paper demonstrated that spleen cells of some strains 
of mice  express  Q6  antigens  or  molecules  with  crossreacting  determinants. 
Indeed,  the  Q6  gene  product  may  be the  CR antigen  recently  described  by 
Sharrow  et  al.  (44).  This  antigen  encoded  by  the  Qa-2  region  is  expressed 
primarily  on  peripheral  T  cells,  Ia-positive  cells,  and  bone marrow  cells,  and 
reacts with  monoclonal  antibodies  20-8-4 and  34-1-2.  The  reactivity could be 
blocked by B6.K1  anti-B6 serum specific for molecules encoded in the Qa and 
Tla regions. Therefore, Sharrow et al. (44) suggested that B6.KI anti-B6 serum 
and  the  anti-H-2  monoclonal  antibodies  detect  distinct  but  spatially  related 
antigenic determinants on the CR antigen. The determinants detected by B6.K1 
anti-B6 serum are absent on K transplantation  antigens, because the reaction of 
monoclonal antibodies 20-8-4 and 34-1-2 with K antigens could not be blocked 
with anti-Qa/Tla region serum. Since Q6/L  d fusion product has a similar pattern 
of reactivities to the CR, and  K b, and  K d antigens,  we subjected it to the same 
type of inhibition analysis and found that it is indistinguishable  by these criteria 
from CR antigen.  Thus,  the Q6 sequence may be a  structural  gene for the CR 
antigen. 
Q6 Gene Product Is Probably a Cell Surface Molecule.  If the Q6 gene product 948  CODING  PROPERTIES  OF  Qa  HYBRID  GENES 
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FICURE  8.  Hydrophilicityprofiles of class I  molecules. Carboxyl-terminal regions of H-2 b 
Q10 (---), Q6 (-- --), and Ka( .. .) proteins are shown. Hydrophobicity values were calculated 
by a computer program similar to that of Kyte and Doolittle (46) and written by S. Kent and 
F. Larsen (personal communication). The positive values correspond to greater hydrophilicity 
values. The program was run at a span setting of 7. The protein sequence starts with the first 
amino acid encoded by exon 5. It corresponds to position 275 in the K d sequence. The solid 
bar below the profile corresponds to K  d region proposed to span the membrane. 
is the CR antigen, it should be an integral membrane protein. Yet the Q6 gene 
differs from typical class I genes in several features. First, the Q6 gene contains 
a stop codon located nine nucleotides after the end of the transmemhrane coding 
region.  If the Q6 protein is translated,  it would be ~40,000  mol wt.  Second, 
there is a charged aspartic acid residue in the middle of the putative transmem- 
brahe region. This observation raised the possibility that the Q6 antigen might 
be secreted, as proposed for the H-2 b Q 10 antigen (39, 45). However, inspection 
of the  amino  acid  hydrophilicity profile  of the  hypothetical  transmembrane 
regions of the Q6,  H-2 b Q10, and K  d polypeptides reveals that the presence of 
the single charged amino acid in the transmembrane segment of the Q6 antigen 
does not alter significantly its hydrophobicity (Fig. 8). When the hydropathy of 
a  given segment of a  protein (19 residues or longer) averages >1.6,  there is a 
high probability that it will span the membrane (46). The mean hydropathy of 
the K  d and K b transmembrane regions, calculated according to the hydrophobic- 
ity  rules  of Kyte  and  Doolittle  (46),  is  2.7  and  2.5,  respectively,  while  the 
corresponding segment of the  H-2  b Q10  antigen is  0.5.  The transmembrane 
segment of the Q6 antigen scores an average hydropathy of 2.5.  Thus,  these 
calculations suggest that Q6 polypeptide is membrane bound. If that is the case, 
the anchoring hydrophilic cytoplasm-bound segment of the Q6 antigen would 
be only four amino acids long, as opposed to ~25 for the transplantation antigens. 
Recent results (47, 48) demonstrated that transplantation antigens with altered 
or truncated cytoplasmic domains can still  be expressed on the cell surface of 
transfected fibroblasts and function as targets for killer T  cells.  When a termi- 
nation  codon  is  placed  in  the  L  a  gene  by  in  vitro  mutagenesis,  so  that  the 
cytoplasmic region is just four residues long, this class I molecule is displayed on 
the cell surface (49). Hence, Q6 probably is an integral membrane protein. 
We have mapped the feature responsible for the absence of Q6 cell surface 
expression on  mouse fibroblasts  to  the  3'  half of the gene.  Several different STROYNOWSKI  ET  AL.  949 
mechanisms could explain this effect. It  is possible  that a  regulatory element 
necessary for the tissue-specific transcription located in the 3' region of the Q6 
gene is inactive in the fibroblasts.  Alternatively, the cell surface expression of 
Q6 molecules may require the interaction of the a3 region or cytoplasmic region 
with  tissue-specific protein(s).  Finally,  the Q6  gene may be a  pseudogene, al- 
though this explanation appears highly unlikely: it has an open reading frame 
throughout, encodes polymorphic determinants expressed on mouse spleen cells, 
has a functional promoter, and, by sequence criteria, appears to be a cell surface 
antigen. We are presently trying to distinguish experimentally among the differ- 
ent possibilities.  Specific probes  for the Q6  gene will  be isolated and used in 
hybridization experiments to test if Q6 gene expression is regulated at the RNA 
level. Since Q6 DNA is most likely a structural gene for the CR antigen, it will 
be introduced into T  cells to determine whether it is displayed on the cell surface. 
Summary 
Coding potential of the Q6 gene from the Qa-2  a region of BALB/c Crgl mice 
was analyzed by a  combination of hybrid class  I  gene construction and DNA- 
mediated gene transfer, Recombinant genes were created by exon shuffling of 
the 5' coding region of the Q6 gene and the 3' coding region ofa gene encoding 
a  transplantation antigen (K  d, D d, or Ld), or the inverse. Some of these hybrid 
class  I genes were expressed in the transfected mouse fibroblasts (L cells).  The 
hybrid class I molecules encoded by the 5' end of the Q6 gene and the 3' end 
of the  L d gene precipitated  as  45,000  mol  wt  molecules associated  with  /32- 
microglobulin. The expression of the hybrid proteins indicates that 926 basepairs 
of the 5' flanking region upstream of the structural Q6 gene contain a promoter 
that functions as a transcription initiation site in L cells. The 3'  portion of the 
Q6 gene appears to be responsible for the lack of cell surface expression of the 
intact Q6 and the hybrid LO/Q6  genes in  mouse fibroblasts.  Accordingly, this 
portion  of the  Q6  class  I  gene  may play  a  regulatory role  in  tissue-specific 
expression. Serological analyses of hybrid Q6 proteins suggested that Q6 may 
be  a  structural  gene  for  CR  (H-2  crossreactive) antigen  found  normally  on 
subpopulations  of lymphocytes. If this  identification is  correct,  Q6  gene will 
define a new category of class I genes encoding ~40,000 mol wt molecules and 
carrying a characteristic truncated cytoplasmic tail. Analysis of L cells transfected 
with Q6 hybrid genes demonstrated also that the cytotoxic T  cells specific for 
Qa-2" region-coded antigens recognize the amino-terminal a l-a2 domain of Q6 
fusion products.  This recognition can be blocked by anti-Qa-2  a alloantiserum 
and monoclonal antibodies reactive with the a3-/32-microglobulin portion of the 
Q6  hybrids.  We  propose  that  the  structural  requirements for the anti-Qa-2 a 
cytotoxic T  lymphocyte-specific epitopes on target molecules are the same as 
for anti-H-2-alloreactive cytotoxic T lymphocyte determinants on transplantation 
antigens and that the mechanism of target recognition is similar in both cases. 
This interpretation is consistent with the following structural similarities found 
in  both  categories of class  I  molecules:  (a)  K  d and  Q6  al-a2  domains share 
serologically defined epitopes. (b) Cytotoxic T lymphocyte-specific  and antibody- 
specific determinants on Q6- and H-2-defined al-a2 domains are not distorted 
in hybrid proteins carrying different polymorphic a3-Bz-microglobulin carboxyi 950  CODING  PROPERTIES  OF  Qa  HYBRID  GENES 
termini.  (c) Amino acid comparisons between  H-2 and  Qa molecules indicated 
that the two groups are almost as closely related to each other as the individual 
members within each group. 
We thank  Drs.  L.  Flaherty and T.  Hansen for antisera and monoclonal antibodies;  K. 
Blackburn and M. Krempin for their excellent technical assistance; Drs. S. Hunt, B. Kim, 
B.  Korber, R. Owen,  B.  Sher,  D. Straus, and M.  Zuniga for the critical reading of the 
manuscript; and C. Katz for the preparation of the manuscript. 
Received  for publication 27 December 1984. 
References 
1.  Forman, J.,  and  L.  Flaherty.  1978.  Identification  of a  new  CML  target  antigen 
controlled by a gene associated with the Qa-2 locus. Immunogenetics. 6:227. 
2.  Klein, J., and C.  L. Chiang.  1978.  A  new locus (H-2T) and the D  end of the H-2 
complex. Immunogenetics. 6:235. 
3.  Fischer-Lindahl,  K.,  B.  Houssman, and V.  M.  Chapman.  1983.  A  new  H-2-1inked 
class  I  gene  whose  expression  depends  on  a  maternally inherited  factor.  Nature 
(Lond.).  306:383. 
4.  Flaherty, L. 1976. The TLA region of the mouse: identification of a new serologically 
defined locus Qa-2. lmmunogenetics.  3:533. 
5.  Flaherty,  L.  1980a.  The  H-2 complex, TLA region and other  genes of the  17th 
chromosome. In Biological Basis for Immunodeficiency. E.  W. Gelfand and H. M. 
Dosch, editors. Raven Press, New York. 99. 
6.  Flaherty, L. 1980b. Tla-region antigens. In The Role of the Major Histocompatibility 
Complex in Immunology. M. E.  Dorf, editor.  Garland Publishing Inc., New York. 
33. 
7.  Schlesinger, M., E. A. Boyse, and L.J. Old. 1965. Thymus cells of radiation chimeras: 
TL phenotype sensitivity to guinea pig serum, and origin from donor cells. Nature 
(Lond.).  304:549. 
8.  Old, L.J., E. A. Boyse, and E. Stockert.  1963. Antigenic properties of experimental 
leukemias.  I.  Serological  studies  in  vitro with  spontaneous and  radiation  induced 
leukemias. J. Natl. Cancer Inst.  31:977. 
9.  Cook, R. G., and N. F.  Landolfi.  1983.  Expression of the thymus leukemia antigen 
by activated peripheral T  lymphocytes. J. Exp. Med.  158:1012. 
10.  Steinmetz, M., K. W. Moore, J. G. Frelinger, B. T. Sher, F.  W. Shen, E. A. Boyse, 
and L. Hood.  1981.  A pseudogene homologous to mouse transplantation antigens: 
transplantation  antigens  are  encoded  by eight  exons  that  correlate  with  protein 
domains. Cell. 25:683. 
11.  Steinmetz, M., A. Winoto, K. Minard, and L. Hood. 1982. Clusters of genes encoding 
mouse transplantation antigens. Cell. 28:489. 
12.  Goodenow, R. S., M. McMillan, A. Orn, M. Nicolson, N. Davidson,J. Frelinger, and 
L.  Hood.  1982a.  Identification of a  BALB/c H-2L  d gene by DNA-mediated gene 
transfer. Science (Wash. DC). 215:677. 
13.  Goodenow, R. S., M. McMillan, M. Nicolson, B. T. Sher, K. Eakle, N. Davidson, and 
L. Hood. 1982b. Identification of the class I genes of the mouse major histocompat- 
ibility complex by DNA-mediated gene transfer. Nature (Lond.).  300:231. 
14.  Winoto,  A.,  M.  Steinmetz,  and  L.  Hood.  1983.  Genetic  mapping  in  the  major 
histocompatibility complex by restriction enzyme site polymorphisms: most mouse 
class I genes map to the Tla complex. Proc. Natl. Acad. Sci. USA. 80:3425. 
15.  Rogers, J. H., and K. R. Willison.  1983. A major rearrangement in the H-2 complex 
of mouse haplotypes. Nature (Lond.).  304:549. 
16.  Oudshoorn-Smoek,  M.,  A.  L.  Mellor,  R. A.  Flavell, and P.  D~mant.  1984.  A  new STROYNOWSKI  ET  AL.  951 
determinant, Qa-m208, detected on T  lymphocytes and transfected L cells by a K  b- 
specific monoclonal antibody. Immunogenetics.  19:461. 
17.  Weiss, E., L. Golden, K. Fahrner,  A. Mellor, J. J. Devlin, H. Bullman, H. Tiddens, 
M.  Bud,  and  R.  A.  Flavell.  1084.  Organization and evolution of the  class  I  gene 
family in  the  major histocompatibility complex of the  C57BL/10  mouse.  Nature 
(Lond.).  310:650. 
18.  Moore,  K.  W.,  B.  T.  Sher,  Y.  H.  Sun,  K.  A.  Eakle,  and  L.  Hood.  1982.  DNA 
sequence of a  gene encoding a  BALB/c mouse L d transplantation antigen.  Science 
(Wash. DC).  215:679. 
19.  Ozato, K., T.  H. Hansen, and D. H. Sachs.  1980.  Monoclonal antibodies to the H- 
2L  d antigen, the products of a third polymorphic locus of the mouse histocompatibility 
complex.J. Immunol.  125:2473. 
20.  Ozato, K., and D. H. Sachs.  1981.  Monoclonal antibodies to mouse MHC antigens. 
III. Hybridoma antibodies reacting to antigens of the H-2  b haplotype reveal genetic 
control of isotype expression. J. lmmunol.  126:317. 
21.  Ozato, K.,  N.  M.  Mayer, and D. H. Sachs.  1982.  Monoclonal antibodies to mouse 
major bistocompatibility antigens. IV. A series of hybridoma clones producing anti- 
H-2  d antibodies and an examination of expression of H-2  d antigens on the surface of 
these cells.  Tranplantation (Baltimore).  34:113. 
22.  Forman, J., j. A. Trial, S. Tonkonogy, and L. Fiaberty. 1982. The Qa-2 subregion 
controls the expression of two antigens recognized by H-2 unrestricted cytotoxic T 
cells.J. Exp. Med.  155:749. 
23.  Stroynowski, I., A. Orn, R. S. Goodenow, M. McMillan, J. Forman, P. R. Brayton, J. 
Frelinger, and L. Hood.  1984. Cytotoxic T  lymphocytes recognize determinants on 
the BALB/c H-2L  d molecule controlled by al and a2 but not c~3 external domains. 
Immunogenetics.  20:141. 
24.  Goodenow, R. S., I. Stroynowski, M.  McMillan, M.  Nicolson, K. Eakle, B. T. Sher, 
N. Davidson, and L. Hood.  1983.  Expression of complete transplantation antigens 
by mammalian cells transformed with truncated class I genes. Nature (Lond.). 301:388. 
25.  McMillan,  M., J. A. Frelinger,  P.  P. Jones, D. P.  Murphy, H. O. McDevitt, and L. 
Hood.  1981.  Structure  of murine  Ia  antigens.  Two-dimensional  electrophoretic 
analysis and high pressure liquid chromatography tryptic peptide maps of products 
of the I-A and I-E subregions and of an associated invariant polypeptide. J. Exp. Med. 
153:936. 
26.  Segal,  D.  M.,  S.  O.  Sharrow, J.  F. Jones,  and  R.  P.  Siraganian.  1981.  Fc  (IgG) 
receptors on rat basophilic leukemia cells. J. lmmunol.  126:138. 
27.  Forman,J., R. S. Goodenow, L. Hood, and R. Ciavarra. 1983. Use of DNA-mediated 
gene  transfer  to  analyze the  role  of H-2L  d in  controlling  the  specificity of anti- 
vesicular stomatitis virus cytotoxic T  cells. J. Exp. Med.  157:1261. 
28.  Evans, G. A.,  D.  H. Margulies,  B.  Shykind, J.  G. Seidman, and  K. Ozato.  1982b. 
Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation 
antigens. Nature (  Lond. ). 300:755. 
29.  Allen, H., D. Wraith, P. Pala, B. Askonas, and R. A. Flavell. 1984. Domain interac- 
tions of H-2 class I antigens alter cytotoxic T  cell recognition sites.  Nature (Lond.). 
309:279. 
30.  Arnold,  B.,  H.-G. Burgert,  V.  Hammann, G.  Hammerling, V.  Kees, and S.  Kvist. 
1984. Cytotoxic T  cells recognize the two amino-terminal domains of H-2K antigens 
in tandem in influenza A infected cells.  Celt. 38:79. 
31.  Davies, D. R., E. A. Padlan and D. M. Segal.  1975. Three-dimensional structure of 
immunoglobulins. Annu. Rev. Biochem. 44:639. 
32.  Reiss, C., G. A.  Evans, D.  H.  Margulies, J. G. Seidman, and S. J. Burakoff.  1983. 
Aliospecific and virus-specific cytolytic T  lympbocytes are restricted to the N or CI 952  CODING  PROPERTIES  OF  Qa  HYBRID GENES 
domain of H-2 antigens  expressed  on  L  cells  after  DNA-mediated gene  transfer. 
Proc. Natl. Acad. Sci.  USA.  80:2709. 
33.  Coligan, J.  E.,  T. J.  Kindt,  H.  Uehara, J.  Martinko,  and  S.  G.  Nathenson.  1981. 
Primary structure of a murine transplantation antigen. Nature (Lond.).  291:35. 
34.  Maloy,  W. L., and Coligan, J. E.  1982. Primary structure of the H-2D  d alloantigen. 
II.  Additional  amino  acid  sequence  information,  localization  of a  third  site  of 
glycosylation and evidence for K and  D  region-specific sequences. Immunogenetics. 
16:11. 
35.  Evans, G. A., D. H. Margulies,  K. Ozato, R. D. Camerini-Otero, andJ. G. Seidman. 
1982.  Structure and expression of a  mouse major histocompatibility antigen gene, 
H-2L  d. Proc. Natl. Acad. Sci.  USA.  79:1994. 
36.  Reyes,  A.  A.,  M.  Schold,  and  R.  B.  Wallace.  1982a.  The  complete  amino  acid 
sequence  of the  murine  transplantation  antigen  H-2D  b as  deduced by molecular 
cloning, lmmunogenetics.  16:1. 
37.  Reyes, A. A., M. Schold, K. Itakura, and R. B. Wallace.  1982b. Isolation ofa cDNA 
clone  for  the  murine  transplantation  antigen  H-2K  b.  Proc.  Natl.  Acad.  Sci.  USA. 
79:3270. 
38.  Kvist,  S.,  L.  Roberts,  and  B.  Dobberstein.  1983.  Mouse  histocompatibility genes: 
structure and organization of the K  a gene. EMBO (Eur. Mol. Biochem.  Org.)J.  2:245. 
39.  Mellor, A. L., E.  M.  Weiss,  M.  Kress,  G. Jay, and R.  A. Flavell.  1984.  A nonpoly- 
morphic class I gene in the murine major histocompatibility complex. Cell  36:139. 
40.  Sher, B.  1984. Studies of class I genes in the major histocompatibility complex of the 
BALB/c mouse. Ph.D. thesis,  California Institute of Technology, Pasadena. 
41.  Ploegh,  H.  L.,  H.  T.  Orr,  and J.  L.  Strominger.  1981.  Major  histocompatibility 
antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I  molecules. 
Cell.  24:287. 
42.  Weiss,  E.  H.,  A.  Mellor,  L.  Golden,  K.  Fahrner,  E.  Simpson, J.  Hurst, and  R.  A. 
Flavell.  1983a.  The structure of a mutant H-2 gene suggests that the generation of 
polymorphism in H-2 genes may occur by gene conversion-like events. Nature (Lond.). 
301:671. 
43.  Weiss, E.,  L. Golden, R.  Zokut, A. Mellor, K.  Fahrner, S. Kvist, and R.  A. Flavell. 
1983b.  The DNA sequence of the H-2K  b gene: evidence for gene conversion as a 
mechanism for the generation of polymorphism in histocompatibility antigens. EMBO 
(Eur. Mol. Biochem.  Org.)J.  2:453. 
44.  Sharrow, S. O., L. Flaherty, and D. H. Sachs. 1984. Serologic cross-reactivity between 
class  I  MHC  molecules and  an  H-2-1inked  differentiation  antigen  as  detected  by 
monoclonal antibodies. J. Exp. Med.  159:21. 
45.  Maloy, W. L., J. E. Coligan, Y. Barra, and G. Jay. 1984. Detection of a secreted form 
of the  murine  H-2 class  I  antigen with an antibody against its predicted carboxyl 
terminus. Proe. Natl. Acad. Sci.  USA.  81:1216. 
46.  Kyte, J., and R. F. Doolittle.  1982. A simple  method for displaying the hydropathic 
character of a protein..]. Mol. Biol.  157:105. 
47.  Zuniga, M. C., B. Malissen,  M. McMillan,  P. R. Brayton, S. S. Clark, J. Forman, and 
L. Hood. 1983. Expression and function of transplantation antigens with altered or 
deleted cytoplasmic domains. Cell.  34:535. 
48.  Murre, C., C. S. Reiss, C. Bernabeu, L. B. Chen, S. J. Burakoff, and J. G. Seidman. 
1984.  Construction,  expression  and  recognition of an  H-2 antigen  lacking its  C- 
terminus. Nature (Lond.).  307:432. 
49.  Edidin,  M.,  and  M.  Zuniga.  1984.  Lateral  diffusion of wild  type and  mutant  L  a 
antigens in L cells.J. Cell Biol. 99:2333. 